Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bioprocessing - Upstream & Downstream

Manufacture Advanced Medicine

Advanced Medicine: Replicating the mAb Success Story

| Stephanie Sutton

How can manufacturing be improved for viral vectors?

Business & Regulation Business Practice

One Vision, One Culture, One Team

| Rich Whitworth

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Manufacture Vaccines

Lending a Helping Hand

| Maria Elena Bottazzi, Bart Fryszczyn

How are industry and academia collaborating to tackle neglected diseases?

Manufacture Advanced Medicine

Manufacturing by Design

| Frederic Revah

Let’s reduce gene therapy manufacturing costs by optimizing cell lines, improving transfectants, and optimizing downstream purification.

Manufacture Bioprocessing - Upstream & Downstream

Biopharma's Big Transformation

| Sponsored by GE Healthcare

Digital technology, data analytics and continuous processing. The world of biopharma is changing rapidly.

Manufacture Bioprocessing - Upstream & Downstream

New Paradigms in Viral Safety with MilliporeSigma

| Sponsored by MilliporeSigma

It is time to rethink traditional approaches to biosafety.

Manufacture Technology and Equipment

The Future of Biopharma – Big Needs and Smart Solutions

| Günter Jagschies, Soon Jae Park

We must never forget unmet needs when developing new medicines.

Manufacture Technology and Equipment

The Innovation Awards 2019

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Manufacture Bioprocessing - Upstream & Downstream

When One Size Doesn't Fit All

| Alison Porter

More complex proteins are coming down the pipe! Next-generation protein expression will require a toolbox of next-generation solutions.

Manufacture Bioprocessing - Upstream & Downstream

Next-Generation Bioprocessing and the Implications for Viral Safety

| Kathy Remington, Michael Phillips

With the focus on next generation bioprocessing, it is important that manufacturers do not forget to re-examine their approach to viral safety.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register